Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8853469 | 0.82 | CHRM2 (0.30) | LMNATSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL6043728 | 0.82 | CHRM2 (0.30) | LMNATSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL28264411 | 0.82 | CHRM2 (0.30) | LMNATSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL110853 | 0.79 | LMNA (0.30) | LMNAHSD17B10 | |
| SCHEMBL15685824 | 0.79 | LMNA (0.30) | LMNAHSD17B10 | |
| SCHEMBL27477536 | 0.79 | ALOX15 (0.36) | LMNATSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL19865074 | 0.79 | LMNA (0.32) | LMNATSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL27783021 | 0.79 | — | — | |
| SCHEMBL11001316 | 0.78 | CTSK (0.34) | LMNATSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL28224248 | 0.77 | DPP4 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106920694-A | Conductive material and capacitor | 财团法人工业技术研究院 | 2017-07-04 | — | — | CN | claimed |
| US-12494326-B2 | Composition for electrolytic capacitor and electrolytic capacitor including the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2025-12-09 | — | — | US | disclosed |
| US-20230107749-A1 | COMPOSITION FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR INCLUDING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2023-04-06 | — | — | US | disclosed |
| CN-113527186-A | Asymmetric catalytic synthesis method of chiral alpha-azaarene tertiary carbon center compound | 河南工业大学 | 2021-10-22 | — | — | CN | disclosed |
| EP-3564238-B1 | FUSED HETEROCYCLIC COMPOUND HAVING OXIME GROUP OR SALTS THEREOF, AGRICULTURAL/HORTICULTURAL INSECTICIDE CONTAINING SAID COMPOUNDS, AND METHOD FOR USING SAID INSECTICIDE | NIHON NOHYAKU CO LTD (JP) | 2021-10-13 | — | — | EP | disclosed |
| CN-110797199-B | Conductive polymer composite material and capacitor | 财团法人工业技术研究院 | 2021-06-18 | — | — | CN | disclosed |
| US-10856548-B2 | Oxime group-containing condensed heterocyclic compound or salt thereof, agricultural and horticultural insecticide comprising the compound or the salt, and method for using the insecticide | NIHON NOHYAKU CO., LTD. (JP) | 2020-12-08 | — | — | US | disclosed |
| US-10790072-B2 | Conductive polymer composite material and capacitor | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2020-09-29 | — | — | US | disclosed |
| US-20200085054-A1 | OXIME GROUP-CONTAINING CONDENSED HETEROCYCLIC COMPOUND OR SALT THEREOF, AGRICULTURAL AND HORTICULTURAL INSECTICIDE COMPRISING THE COMPOUND OR THE SALT, AND METHOD FOR USING THE INSECTICIDE | NIHON NOHYAKU CO., LTD. (JP) | 2020-03-19 | — | — | US | disclosed |
| CN-110797199-A | Conductive polymer composite material and capacitor | 财团法人工业技术研究院 | 2020-02-14 | — | — | CN | disclosed |
| CN-104781424-B | The MIR-18B of the therapeutic targets of marker and treating cancer as cancer progression | 萨特西湾医院 | 2018-11-23 | — | — | CN | disclosed |
| US-9221771-B2 | Method for the preparation of substituted oxazolidinones | SANDOZ AG (CH) | 2015-12-29 | — | — | US | disclosed |
| EP-2697209-B1 | METHOD FOR THE PREPARATION OF SUBSTITUTED OXAZOLIDINONES | SANDOZ AG (CH) | 2015-09-23 | — | — | EP | disclosed |
| US-20140213784-A1 | METHOD FOR THE PREPARATION OF SUBSTITUTED OXAZOLIDINONES | SANDOZ AG (CH) | 2014-07-31 | — | — | US | disclosed |
| EP-2697209-A1 | METHOD FOR THE PREPARATION OF SUBSTITUTED OXAZOLIDINONES | Sandoz AG (CH) | 2014-02-19 | — | — | EP | disclosed |
| WO-2012140061-A1 | METHOD FOR THE PREPARATION OF SUBSTITUTED OXAZOLIDINONES | SANDOZ AG (CH) | 2012-10-18 | — | — | WO | disclosed |
| WO-2011108744-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2011-09-09 | — | — | WO | disclosed |
| EP-0934938-B1 | SUBSTITUTED BENZOYLAMINOTHIAZOLE DERIVATIVES AND DRUGS CONTAINING THE SAME | ZERIA PHARM CO LTD (JP) | 2003-01-15 | — | — | EP | disclosed |
| US-6121301-A | ADMINISTERING TO PREVENT OR TREAT GASTROINTESTINAL DYSMOTILITY; COMPOUNDS SUCH AS 2-((N-(3-CYANOBENZOYL)AMINO)-4-((3-DIISOPROPYLAMINOPROPYL)AMINOCARBONYL)-1,3-THIAZOLE | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2000-09-19 | — | — | US | disclosed |
| EP-0934938-A1 | SUBSTITUTED BENZOYLAMINOTHIAZOLE DERIVATIVES AND DRUGS CONTAINING THE SAME | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200085054-A1 | OXIME GROUP-CONTAINING CONDENSED HETEROCYCLIC COMPOUND OR SALT THEREOF, AGRICULTURAL AND HORTICULTURAL INSECTICIDE COMPRISING THE COMPOUND OR THE SALT, AND METHOD FOR USING THE INSECTICIDE | OXSR1, CBR3, OSR1 | LMNA 3180/4885TSHR 1347/4885CHRM2 194/4885 |
| US-10856548-B2 | Oxime group-containing condensed heterocyclic compound or salt thereof, agricultural and horticultural insecticide comprising the compound or the salt, and method for using the insecticide | OXSR1, CBR3, OSR1 | LMNA 3180/4885TSHR 1347/4885CHRM2 194/4885 |
| US-20140213784-A1 | METHOD FOR THE PREPARATION OF SUBSTITUTED OXAZOLIDINONES | OXA1L, XDH, AOX1 | LMNA 2033/4885TSHR 3893/4885CHRM2 4272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.